Aligos Therapeutics, Inc

1 Corporate Dr Ste 2
South San Francisco, CA 94080

Aligos Therapeutics, Inc. is a biotechnology company based in South San Francisco, CA, focused on developing best-in-class therapies for liver and viral diseases, particularly chronic hepatitis B virus infection and metabolic dysfunction-associated steatohepatitis. With a strong foundation in medicinal chemistry and biology, the company aims to address significant unmet medical needs through targeted drug development.

The company's pipeline includes innovative oral small molecule therapies, such as ALG-000184, a capsid assembly modulator for chronic HBV infection, and ALG-055009, a thyroid hormone receptor beta agonist for MASH. Aligos is committed to improving patient outcomes by leveraging the expertise of its experienced team, which has a successful track record from discovery to commercialization in hepatology and virology.

Generated from the website

Own this business?
See a problem?

You might also like

United StatesCaliforniaSouth San FranciscoAligos Therapeutics, Inc

Partial Data by Infogroup (c) 2025. All rights reserved.